Global Pharma Grade Sodium Bicarbonate Market Size, Share, Trends, Growth and Forecast 2030
Pharma Grade Sodium Bicarbonate Market By Application (Excipients, Toothpaste, Tablet Coating, Hemodialysis, Antacids, Active Pharmaceutical Ingredient (API), And Others), By Grade (Fine and Coarse), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023-2030
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 250.89 million | USD 335.26 million | 3.69% | 2022 |
Description
What is Pharma Grade Sodium Bicarbonate Market Size?
The global pharma grade sodium bicarbonate market size was worth around USD 250.89 million in 2022 and is predicted to grow to around USD 335.26 million by 2030 with a compound annual growth rate (CAGR) of roughly 3.69% between 2023 and 2030. According to recent market research, the rising demand for premium pharmaceutical components has been the primary factor driving the Pharma Grade Sodium Bicarbonate Market to continuous expansion. It is expected that the market size will continue to grow, with major players in the industry making a contribution to the overall share.
Global Pharma Grade Sodium Bicarbonate Market: Overview
Sodium bicarbonate in common language is known as baking soda. Pharma grade sodium bicarbonate is generally used for systemic alkalizer, electrolyte replenishing, and in contemporary cleaning solutions as a pH buffering agent. The growing popularity of the global pharma grade sodium bicarbonate market is due to the increasing use of sodium bicarbonate in the pharmaceutical industry, especially in regions with a high population of geriatric people.
Global Pharma Grade Sodium Bicarbonate Market: Growth Factors
The major growth driver in the global pharma grade sodium bicarbonate market is the rise in the consumption of sodium bicarbonate by the pharmaceutical industry. The popularity of sodium bicarbonate can be attributed to the product’s utilization as an active pharmaceutical ingredient (API). It is also extensively used as an excipient for treating metabolic acidosis and hemodialysis, cardiac arrest, extracorporeal blood circulation, and uncontrolled diabetics, among another primary lactic acidosis of severe degree. In addition, there is an increase in the consumption of sodium-based medications all over the world, due to the growing geriatric population. API is expected to emerge as the dominant chief ingredient for drug formulations, as it enhances the capabilities of various drugs. Furthermore, the application of pharma grade sodium bicarbonate for hemodialysis is also projected to increase in the upcoming years. Thus, these are some of the factors that are fuelling the growth of the global market for pharma grade sodium bicarbonate.
Global Pharma Grade Sodium Bicarbonate Market: Segmentation
The global pharma grade sodium bicarbonate market can be divided based on application and grade.
On the basis of application, the market for pharma grade sodium bicarbonate can be fragmented into excipients, toothpaste, tablet coating, hemodialysis, antacids, and active pharmaceutical ingredient (API), among others. The API segment is expected to dominate the market for pharma-grade sodium bicarbonate in the upcoming years. This is due to its increasing use in producing effervescent tablets apart from being used as an agent to enhance drug capabilities.
Based on grade, the pharma grade sodium bicarbonate market can be categorized into fine and coarse.
Pharma Grade Sodium Bicarbonate Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Pharma Grade Sodium Bicarbonate Market Research Report |
| Market Size in 2022 | USD 250.89 million |
| Market Forecast in 2030 | USD 335.26 million |
| Growth Rate | CAGR of 3.69% |
| Number of Pages | 214 |
| Key Companies Covered | Novacarb, CIECH, Tronox Alkali Corporation, Tosoh Corporation, Jost Chemical Company, Tata Chemicals, Natural Soda, Church and Dwight, GHCL Ltd., Solvay, Others |
| Segments Covered | By Application, By Grade, And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2022 |
| Historical Year | 2017 - 2021 |
| Forecast Year | 2023 - 2030 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Pharma Grade Sodium Bicarbonate Market: Regional Analysis
Based on regions, the global market for pharma grade sodium bicarbonate can be divided into five main regions: North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. The North American region is anticipated to dominate the pharma grade sodium bicarbonate market in the upcoming years. This is due to the development of the pharmaceutical sector in this region along with high adoption rates related to active pharmaceutical ingredients and increasing demand for excipients in the region. In the Asia Pacific region, the increasing geriatric population is anticipated to fuel the expansion of the pharmaceutical industry. This, in turn, will increase the consumption of active pharmaceutical ingredients and antacids, which will drive the demand for the market for pharma grade sodium bicarbonate in the upcoming years.
Global Pharma Grade Sodium Bicarbonate Market: Competitive Players
- Novacarb
- CIECH
- Tronox Alkali Corporation
- Tosoh Corporation
- Jost Chemical Company
- Tata Chemicals
- Natural Soda
- Church and Dwight
- GHCL Ltd.
- Solvay
- Others
Global Pharma Grade Sodium Bicarbonate Market: Segment Analysis
By Application
- Excipients
- Toothpaste
- Tablet Coating
- Hemodialysis
- Antacids
- Active Pharmaceutical Ingredient (API)
- Others
By Grade
- Fine
- Coarse
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table Of Content
FrequentlyAsked Questions
This is high-purity sodium bicarbonate for pharmaceutical use. It is used in medicines and medical formulations
The global Pharma Grade Sodium Bicarbonate market is expected to be driven by the pharmaceutical formulations and medical applications. Demand for high-purity excipients and antacids supports market growth.
According to study, the global Pharma Grade Sodium Bicarbonate market size was worth around USD 250.89 Million in 2022 and is predicted to grow to around USD 335.26 Million by 2030.
The global Pharma Grade Sodium Bicarbonate market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 3.69% during the forecast period from 2023-2030.
The global Pharma Grade Sodium Bicarbonate industry is projected to be challenged by Challenges include strict GMP compliance and quality consistency.
The Opportunities include dialysis, antacid formulations, injectable buffering, and hospital demand will offer significant growth opportunities in the Pharma Grade Sodium Bicarbonate market.
High-purity injectable and dialysis grades; strict GMP compliance; demand from critical care applications are the emerging trends and innovations impacting the Pharma Grade Sodium Bicarbonate market.
The global Pharma Grade Sodium Bicarbonate market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Pharma Grade Sodium Bicarbonate market are; Novacarb, CIECH, Tronox Alkali Corporation, Tosoh Corporation, Jost Chemical Company, Tata Chemicals, Natural Soda, Church and Dwight, GHCL Ltd., Solvay, Others and others.
The report explores crucial aspects of the Pharma Grade Sodium Bicarbonate market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
